Medicines Australia welcomes new PBAC Chair
Medicines Australia chief executive Dr Brendan Shaw today welcomed the appointment of Dr Suzanne Hill as Chair of the Pharmaceutical Benefits Advisory Committee.
Dr Shaw also congratulated the outgoing Chair Professor Lloyd Sansom, who vacates the position after an illustrious 10 years service.
“Medicines Australia congratulates Dr Hill on her appointment and we look forward to working with her in her new role as Chair of the PBAC,” Dr Shaw said.
“Dr Hill is eminently qualified to bring to the PBAC the high degree of integrity and independence that were the hallmarks of Professor Sansom’s tenure.
“I am sure Dr Hill will bring astute leadership to the PBAC and contribute significantly to ensuring the Committee continues to be held in high regard internationally.
“Medicines Australia looks forward to working with Dr Hill in the years ahead to continue to support the development of the PBAC process in the interests of the community.
“Medicines Australia congratulates Professor Sansom on his distinguished stewardship of the PBAC.
“I personally thank him and wish him well in his future endeavours. He has justifiably earned the trust and respect of industry over the last decade.
“Over that time, industry has worked well with the PBAC to develop the rigor, transparency and community engagement of the process, which now benefits all Australians.
“Under his chairmanship, the PBAC process has become much more open and transparent. The Committee has worked collaboratively with industry to deliver the best outcomes to the community.”
Media Communications Manager
Phone: 0419 220 293